Entering text into the input field will update the search result below

BioLife Solutions sees 2016 top line up 24%; shares ahead 4% premarket

  • BioLife Solutions (NASDAQ:BLFS) announces preliminary 2016 and Q4 revenue of $8.2M (+28%) and $2.2M (+24%) respectively.
  • BioLife's CryoStor and HypoThermosol are now embedded in 240 customer validations and clinical trials, an increase of 20% yoy.
  • 2017 Guidance: biopreservation media revenue growth of 20-25%; gross margin of 55% to 60%, operating expenses: $8M - $9M and positive quarterly EBITDA by the end of the year.
  • Shares are up 4% premarket on light volume.
  • Recent executive appointments: Roderick de Greef as Chief Financial Officer, Karen Foster as Vice President of Operations and Jim Mathers as Vice President of Global Sales.

Recommended For You

About BLFS Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
BLFS--
BioLife Solutions, Inc.